We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Mhlongo, Sanele E.![]() |
|
dc.contributor.author | Naidoo, Thinagrin D.![]() |
|
dc.contributor.author | Makhathini, Bongumusa S.![]() |
|
dc.date.accessioned | 2021-08-24T08:57:59Z | |
dc.date.available | 2021-08-24T08:57:59Z | |
dc.date.issued | 2020 | |
dc.description.abstract | BACKGROUND: A study was conducted to determine the accuracy of preoperative endometrial sampling histology type and tumour grade results compared with the final postoperative diagnosis. METHODS: This was a retrospective chart audit of patients with endometrial cancer and atypical hyperplasia admitted to Grey’s Hospital in Pietermaritzburg, South Africa, from January 2013 to December 2017. RESULTS: Sixty patients met the inclusion criteria. For endometrial cancer histological types, the accuracy of preoperative endometrial sampling was 94.7% (36/38) for endometrioid adenocarcinoma, 42.9% (3/7) for serous papillary carcinoma, 85.7% (6/7) for carcinosarcoma and 75% (9/12) for atypical hyperplasia. A kappa value of 0.825 was obtained with a p-value of 0.000 for agreement between preoperative endometrial sampling and the final postoperative diagnosis. For endometrioid adenocarcinoma tumour grading 1–3 (G1–3), only 16/38 (42.1%) patients met the criteria to compare the pre- and postoperative results, which were as follows: of the eight patients with grade 1 tumour on preoperative sampling one patient (1.25%) was upgraded to grade 2 tumour postoperatively. There were no changes in tumour grading for grade 2 and 3 tumours, 3/3 and 5/5 respectively. CONCLUSION: Our study results for endometrioid adenocarcinoma are comparable to previous literature. However, there were significant discrepancies for non-endometrioid adenocarcinoma. Deficiencies that need to be addressed by laboratories in order to improve both preoperative surgical staging and postoperative adjuvant therapy planning were also highlighted. | en_ZA |
dc.description.department | Obstetrics and Gynaecology | en_ZA |
dc.description.librarian | hj2021 | en_ZA |
dc.description.uri | http://www.sajgo.co.za/index.php/sajgo/about | en_ZA |
dc.identifier.citation | Mhlongo, S.E., Naidoo, T.D. and Makhathini, B.S. 2020, 'Discrepancy between preoperative endometrial sampling and hysterectomy diagnosis in endometrial cancer', Southern African Journal of Gynaecological Oncology, vol. 12, no. 1, pp. 13–16. | en_ZA |
dc.identifier.issn | 2074-2835 (print) | |
dc.identifier.issn | 2220-105X (online) | |
dc.identifier.other | 10.1080/20742835.2020.1754659 | |
dc.identifier.uri | http://hdl.handle.net/2263/81466 | |
dc.language.iso | en | en_ZA |
dc.publisher | NISC (Pty) Ltd, Medpharm Publications, and Informa UK Limited | en_ZA |
dc.rights | © 2020 The Author(s). Co-published by NISC Pty (Ltd) and Informa UK Limited, trading as Taylor and Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License creativecommons.org/licenses/by-nc/4.0/ (the “License”). | en_ZA |
dc.subject | Endometrial cancer | en_ZA |
dc.subject | Preoperative endometrial sampling | en_ZA |
dc.subject | Hysterectomy diagnosis | en_ZA |
dc.title | Discrepancy between preoperative endometrial sampling and hysterectomy diagnosis in endometrial cancer | en_ZA |
dc.type | Article | en_ZA |